Abortion Pill Prax -

Mike Prax Turned His Back on Alaska's Unborn Children

When it was time for North Pole Republican Mike Prax to give unborn babies the benefit of the doubt, he refused and joined Democrats and abortion activists by co-sponsoring, and voting several times to advance Abortion Pill expanding bill, HB 195.

When HB 195 was not yet clearly understood to expand Mifepristone Abortion Pill distribution from 1 to 300 locations through Alaska’s pharmacies, Mike Prax lined up in favor of abortion activists and Big Pharma.

When Alaska Right to Life Members showed Mike Prax how HB 195 could legalize abortion pill distribution through pharmacies, he told them to form committees and write long letters to politicians.

When the Alaska Right to Life Executive Director met with Mike Prax, he shrugged the concerns off as irrelevant to the more important question: how to improve rural pharmacy access in Alaska.

When the question was called and Mike Prax should have given unborn babies the benefit of the doubt, Mike Prax TURNED HIS BACK ON THE UNBORN and doubled – down on his support for HB 195.

Because HB 195 allows broad independent pharmacist prescription authority;

Because HB 195 allows unrestricted Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense otherwise restricted drugs under Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense Mifepristone abortion pills directly through their pharmacies.

Mike Prax voted to expand abortion pill access through 300(+) Alaskan pharmacies through HB 195.

May 2, 2025 Mike Prax voted to ADVANCE HB 195 from the Health and Social Services Committee.

May 16, 2025 Mike Prax Co-Sponsored HB 195.

May 15, 2026 Mike Prax voted to KILL Pro-Life Amendment 1 in the Alaska House.

May 15, 2026 Mike Prax voted to PASS HB 195 from the Alaska House.

June 19, 2026 Mike Prax voted to OVERRIDE Governor Dunleavy’s veto of HB 195.

ABORTION PILL BILL HB 195

In a very broad sense, HB 195 is a pharmacy modernization/innovation bill that is written so broadly that pharmacists gain direct and indirect drug prescription authority.

The direct prescription authority comes through the bill’s plain text:

Patient care services include prescribing, and administering drugs.
Pharmacists can independently prescribe drugs.

In the case that a pharmacist does not have the specialization or licensing to prescribe certain drugs, he must enter a Collaborative Practice Agreement – more below.

“* Sec. 34. AS 08.80.337(b) is amended to read:

(b) A pharmacist may independently provide patient care services…”

“*Sec. 35. AS 08.80.337(d) is amended to read:

(d) In this section, “patient care services“

(1) means medical care services, including the prescription or

administration of a drug or device to a patient,”

A plain reading of the bill does not indicate that pharmacists will have direct prescription authority for Mifepristone abortion pills – the kind that Planned Parenthood dispenses for abortions up to 11 weeks.

The number two abortion pill – Misoprostol – can be prescribed and dispensed by pharmacists when the bill becomes effective January 1, 2027.

The indirect abortion pill prescription mechanism inside HB 195 is the Collaborative Practice Agreements.

Sec. 33. AS 08.80.337(a) is amended to read:

(a) A pharmacist may, under a collaborative practice agreement with a written

protocol approved by a practitioner who is not a pharmacist, provide patient care

services. The collaborative practice agreement must define the nature and scope

of patient care services the pharmacist may provide under the agreement.

Collaborative Practice Agreements, or CPAs, are contracts between a prescriber (doctor, physician assistant, nurse practitioner, etc.) that define how each one operates within a joint doctor/pharmacist practice. It’s like a Realtor and a Mortgage Lender sharing an office and working together (obvious differences aside).

A CPA is simply a prescriber (doctor, nurse practitioner, nurse midwife, or physician assistant) and pharmacist joint practice.

In the abortion pill context, CPAs allow abortion doctors to delegate their abortion pill prescribing and dispensing authority to pharmacists they partnered with under a CPA partners.

The doctor (prescribing partner) writes the rules and protocols for the CPA. He may also treat patients, prescribe and administer drugs.

At the same time, the pharmacist treats patients, prescribes, administers, and dispenses drugs — including abortion pills — within the boundaries set by the prescribing doctor.

In our case, that doctor, nurse practitioner, or nurse midwife, is an abortionist.

Collaborative Practice Agreement rules, protocols, and limits are defined by the agreement itself. In other words, the State Medical Board and the Pharmacy Board are both prohibited from regulating CPA’s.

Sec. 08.02.150. Regulation of collaborative practice agreements.

(a) The department or a board may not

(1) require a pharmacist to pay a fee to enter into, or provide patient

care services under, a collaborative practice agreement;

(2) require department or board approval of a collaborative practice agreement;

(3) define the nature and scope of patient care services a pharmacist

provides under a collaborative practice agreement; or

(4) otherwise regulate collaborative practice agreements.

Because HB 195 allows broad independent pharmacist prescription authority;

Because HB 195 allows unrestricted Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense otherwise restricted drugs under Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense Mifepristone abortion pills directly through their pharmacies.

Mike Prax repeatedly voted for abortion pill access in and through 300(+) Alaskan pharmacies through HB 195.

Read the full text HERE.

The Abortion Pill Smokescreen

After Alaska Right to Life Members put tremendous pressure on members of the Legislature and stalled the bill in the House Finance Committee, abortion activist and bill sponsor Genevieve Mina offered an amendment through Republican Elexie Moore.

Moore pitched the amendment as a pro-life amendment that would block Mifepristone prescriptions and dispensing through pharmacies.

But you’ve got to ask when do abortion activists write, let alone offer pro-life amendments to anything.

Simple: THEY DO NOT. EVER.

The amendment was a smokescreen; autumn trees without fruit, or clouds without rain… in other words, an amendment without meaning.

How the amendment works within HB 195:

*Sec. 35. AS 08.80.337(d) is amended to read:

(d) In this section, “patient care services“

(2) does not include the prescription or administration of the

following drugs unless the drug is being used for the treatment of an opioid use

disorder in a clinic:

(B) a drug that may only be prescribed or administered

after completing a certified education program required by

(i) the manufacturer; or

(ii) the United States Food and Drug

Administration, including by a risk evaluation and mitigation

strategy; or

may only be dispensed at a pharmacy that

(i) is authorized by the manufacturer to dispense the

drug; or

(ii) meets a requirement to dispense the drug under

federal law.

What all that means is if either the FDA or the drug manufacturer requires certified education programs to be completed before prescribing or dispensing a drug, then Mifepristone cannot be prescribed.

But the FDA does NOT require a certified education program of any kind with Mifepristone. So, the limitation does NOT apply to Mifepristone.

The FDA’s Risk Evaluation Mitigation Strategies (REMS) do NOT require a certified education program of any kind with Mifepristone. The limitation does NOT apply to Mifepristone.

Mifepristone’s manufacturers do NOT require a certified education program of any kind with Mifepristone. The limitation does NOT apply to Mifepristone.

Next, there is no indication that Mifepristone is not ‘generally available’ at pharmacies.

Additionally, Mifepristone is not dispensed by authorized pharmacies, but by certified pharmacies.

Wait, you say. You’re splitting hairs. Authorized or certified pharmacies, it’s all the same.

Yes, I am splitting hairs. Just as tightly as the bill authors split hairs.

But the certification process (below) imposed by the FDA’s REMS and by the manufacturers is very different than obtaining an authorization.

Finally, as you’ll see below, none of these restrictions apply to prescribers (doctors, physician assistants, nurse practitioners, etc.), and therefore, they do not apply to pharmacists operating within Collaborative Practice Agreements.

Let’s apply a little common sense to these last two lines: how many drugs are in pharmacies that do not have some type of authorization by either the manufacturer, some federal law, or both? Probably none. Again, words without meaning.

GBP MIFEPRISTONE REMS PROGRAM

GenBioPro is a leading mifepristone and misoprostol manufacturer. Their Mifepristone REMS Program shows that the Prescriber Agreement Form is the only ‘Certification‘ requirement.

Below you’ll see what is required to become a certified prescriber – and pharmacist.

GBP Certified Prescribers

DISPENSING GBP MIFEPRISTONE

Certified Pharmacists

As you can see, the Certified Prescriber and the Certified Pharmacist must only be qualified in their respective fields – and there is nothing in the Prescriber Agreement – nor in the FDA REMS – that prohibits pharmacists from prescribing mifepristone, especially within a Collaborative Practice Agreement.

Next, HB 195 is written so that it can be broadly interpreted to create independent misoprostol-only abortion prescribing authority.

Or it can be narrowly interpreted so that CPAs are needed to create the framework for abortion doctors to delegate their abortion pill prescribing, administering, or dispensing authority to their pharmacist CPA partners.

Since pharmacists were not specifically named in the 2024 Planned Parenthood v. Alaska lawsuit in which the physician-only rule was permanently enjoined (blocked), we should take the narrow approach to interpreting HB 195.

Therefore, it is within the Collaborative Practice Agreement that abortion pill authority is delegated from the abortion doctor to the pharmacist.

And since the CPA is self-defining and cannot be regulated by the State, HB 195 has created a clear pathway to pharmacists prescribing, administering, or dispensing abortion pills.

Regardless of how HB 195 is interpreted, the bill was advanced, amended, and passed by legislators of both parties with little regard for women’s health and safety, and with no regard for the pre-born images of God who will be murdered by abortion pills.

When Mike Prax should have given unborn babies the benefit of the doubt, he TURNED HIS BACK ON THE UNBORN and doubled – down on his support for HB 195.

Because HB 195 allows broad independent pharmacist prescription authority;

Because HB 195 allows unrestricted Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense otherwise restricted drugs under Collaborative Practice Agreements;

Because HB 195 allows pharmacists to prescribe and dispense Mifepristone abortion pills directly through their pharmacies.

Mike Prax voted to expand abortion pill access through 300(+) Alaskan pharmacies through HB 195.

Mike Prax deserves just as much benefit of the doubt as he gave unborn babies: NONE.

QUESTIONS & CONTACT

📞 CALL me at (907) 753-6397

📧 EMAIL me at PATMARTIN@ALASKARIGHTTOLIFE.ORG

GET HELP

DONATE

ABOUT US

END ABORTION NOW

ABOUT US